Free Trial

Caliber Wealth Management LLC KS Boosts Stake in Synopsys, Inc. $SNPS

Synopsys logo with Computer and Technology background

Key Points

  • Caliber Wealth Management LLC KS significantly increased its stake in Synopsys, Inc. by 141.9%, holding shares now valued at approximately $1.58 million as of the last SEC filing.
  • Synopsys reported a Q3 earnings miss with an EPS of $2.30, falling short of the $3.75 consensus estimate, despite year-over-year revenue growth of 14% to $1.74 billion.
  • Institutional investors now own 85.47% of Synopsys stock, indicating strong institutional interest amidst a range of investment ratings and adjusted price targets from various analysts.
  • Five stocks to consider instead of Synopsys.

Caliber Wealth Management LLC KS increased its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 141.9% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 3,084 shares of the semiconductor company's stock after buying an additional 1,809 shares during the quarter. Caliber Wealth Management LLC KS's holdings in Synopsys were worth $1,581,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in SNPS. Cornerstone Planning Group LLC boosted its holdings in shares of Synopsys by 275.0% in the first quarter. Cornerstone Planning Group LLC now owns 60 shares of the semiconductor company's stock valued at $25,000 after acquiring an additional 44 shares during the period. Saudi Central Bank acquired a new position in shares of Synopsys in the 1st quarter valued at $26,000. Clal Insurance Enterprises Holdings Ltd raised its position in Synopsys by 441.7% in the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 65 shares of the semiconductor company's stock valued at $28,000 after purchasing an additional 53 shares during the last quarter. Independence Bank of Kentucky boosted its stake in Synopsys by 120.0% during the 2nd quarter. Independence Bank of Kentucky now owns 55 shares of the semiconductor company's stock worth $28,000 after purchasing an additional 30 shares during the period. Finally, Princeton Global Asset Management LLC grew its position in Synopsys by 481.8% during the 2nd quarter. Princeton Global Asset Management LLC now owns 64 shares of the semiconductor company's stock worth $33,000 after purchasing an additional 53 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Trading Up 1.3%

NASDAQ:SNPS opened at $459.04 on Wednesday. The stock has a fifty day moving average price of $519.12 and a two-hundred day moving average price of $511.47. The stock has a market capitalization of $85.27 billion, a price-to-earnings ratio of 36.03, a PEG ratio of 5.00 and a beta of 1.10. The company has a debt-to-equity ratio of 0.52, a quick ratio of 1.51 and a current ratio of 1.62. Synopsys, Inc. has a 1 year low of $365.74 and a 1 year high of $651.73.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 EPS for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a return on equity of 10.82% and a net margin of 31.04%.The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.77 billion. During the same quarter in the previous year, the firm posted $3.43 earnings per share. Synopsys's revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS. Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts anticipate that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

SNPS has been the subject of a number of research reports. KeyCorp reduced their target price on shares of Synopsys from $660.00 to $590.00 and set an "overweight" rating for the company in a report on Wednesday, September 10th. Morgan Stanley dropped their price target on Synopsys from $715.00 to $510.00 and set an "overweight" rating on the stock in a research report on Thursday, September 11th. Stifel Nicolaus decreased their price objective on Synopsys from $650.00 to $550.00 and set a "buy" rating for the company in a research report on Wednesday, September 10th. Zacks Research downgraded Synopsys from a "hold" rating to a "strong sell" rating in a research note on Friday, September 12th. Finally, BNP Paribas assumed coverage on Synopsys in a research note on Thursday, October 2nd. They set an "underperform" rating and a $425.00 price target for the company. Ten research analysts have rated the stock with a Buy rating, five have issued a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat.com, Synopsys has an average rating of "Hold" and an average price target of $569.67.

Get Our Latest Report on Synopsys

Insider Activity at Synopsys

In related news, Director Robert G. Painter bought 350 shares of the company's stock in a transaction on Thursday, September 11th. The stock was bought at an average cost of $425.44 per share, with a total value of $148,904.00. Following the completion of the acquisition, the director owned 2,291 shares in the company, valued at approximately $974,683.04. This represents a 18.03% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of Synopsys stock in a transaction that occurred on Monday, September 22nd. The shares were sold at an average price of $500.90, for a total transaction of $4,945,385.70. Following the sale, the chief accounting officer owned 20,520 shares of the company's stock, valued at approximately $10,278,468. The trade was a 32.48% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 30,894 shares of company stock valued at $16,760,783. 0.62% of the stock is owned by corporate insiders.

About Synopsys

(Free Report)

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.